Uriach in the news
Leading natural consumer healthcare
Tamtam found 20 recent articles about Uriach.
- Desayuno empresarial con Oriol Segarra, CEO de Grupo Uriach
Oriol Segarra, CEO of Grupo Uriach, will speak at a business breakfast organized by Grant Thornton and Círculo Ecuestre about his company's transformation, leadership, and challenges.
- Uriach eleva su facturación un 3 %, hasta los 492 millones, en un 2025 de "consolidación" Por EFE
Uriach achieved 492 million euros in revenue and 82 million euros in EBITDA during a 2025 fiscal year focused on operational consolidation and strategic preparation for future acquisitions.
- “El consumidor es cada vez más exigente y demanda conocer el origen de los productos que consume”
Uriach is integrating vertical farming and B Corp principles into its natural healthcare supply chain to ensure ingredient traceability and environmental sustainability.
- Uriach cierra el 2025 con una facturación de 492 millones, un 3% más
Uriach reached 492 million euros in revenue in 2025 by shifting its focus from aggressive acquisitions to organic growth and operational consolidation.
- Uriach incrementa un 3% las ventas el 2025 y roza los 500 M€ en un año marcado por la consolidación de sus negocios
Uriach achieved nearly 500 million euros in revenue for 2025 and plans to focus on organic growth and operational efficiency in 2026.
- Uriach crece hasta los 492 millones y mejora un 13% su Ebitda en un año de consolidación
Uriach reported 492 million euros in revenue for 2025 and is prioritizing operational efficiency and subsidiary integration following years of rapid international expansion.
- Elecciones al Orfeó Català: Joaquim Uriach opta a la reelección con una junta con peso empresarial
Joaquim Uriach, a director of the natural healthcare firm Uriach, seeks re-election to lead the Orfeó Català cultural institution and its foundation.
- Uriach roza los 500 millones en ventas y sube el ebitda un 13%
Uriach reached 492 million euros in sales and increased its EBITDA by 13% while shifting focus toward operational integration and future European expansion.
- El grupo Uriach, cerca de la meta de los 500 millones, opta por consolidar el negocio en Europa
Uriach reached 492 million euros in revenue in 2025 and is now focusing on consolidating its European leadership in natural consumer healthcare.
- El beneficio bruto de Uriach sube un 13%, hasta 82 millones, pese al freno en el mercado
Uriach achieved 492 million euros in revenue and 82 million euros in gross profit by focusing on natural health products and operational restructuring.
- Uriach alcanza los 500 millones en ventas y se prepara para volver a crecer con compras
Uriach achieved nearly 500 million euros in sales and is preparing to relaunch its European acquisition strategy after a period of operational consolidation.
- Uriach increases sales by 3% in 2025 and approaches €500M in a year marked by the consolidation of its businesses
Uriach reached nearly €500M in 2025 revenue and plans to pause acquisitions in 2026 to focus on organic growth and European market consolidation.
- Uriach roza los 500 millones en ventas e inicia un nuevo ciclo de adquisiciones
Uriach reached 492 million euros in sales and is preparing for a new phase of international acquisitions.
- Woments, la nueva marca de Uriach de suplementación natural enfocada en la menopausia
Uriach has launched Woments, a natural supplement brand designed to manage menopause symptoms and improve well-being for women aged 45 to 55.
- Uriach suma a su consejo dos miembros de la sexta generación
Uriach has expanded its board of directors to eleven members by appointing two sixth-generation family members with pharmaceutical and commercial expertise.
- Uriach exceeds its objectives and will invoice more than 500 million this year
Uriach is set to surpass €500 million in revenue through natural healthcare acquisitions and strong international growth.
- ICG gets unconditional EU approval for Uriach and Ineldea acquisition
The EU has approved the acquisition of Uriach and Ineldea by ICG without any conditions.
- Deloitte Legal Advises Uriach on Sale of 30% Stake to ICG
Uriach has sold a 30% minority stake to investment firm ICG for 250 million euros to support its growth strategy.
- Grupo J. Uriach acquires the German group Pascoe: Advisors
Uriach is acquiring German healthcare group Pascoe to expand its European footprint and reach a 500 million euro revenue goal.
- Uriach on delivering award-winning botanical solutions for global populations
Uriach develops award-winning natural healthcare products including bilayer tablets for sleep, cholesterol management, and intestinal regularity.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like Uriach?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies